209 |
Overweight patients:Lesion type acyanotic |
NA: A-CHD |
unrelated |
211 |
Overweight patients: Lesion type cyanotic |
NA: C-CHD |
unrelated |
212 |
Obese patients: Lesion type acyanotic |
isolated CHD/non-isolated CHD: A-CHD/C-CHD/NA |
unrelated |
472 |
the mother's education status (Low education level) |
NA: NA |
unrelated |
519 |
percent predicted peak expiratory flow rate(PEFR) |
isolated CHD: ASD/VSD/TGA/DILV/TA/TOF/PS/TA/EA |
unrelated |
521 |
percent predicted forced expiratory flow rate at 50% of forced vital capacity(FEF50) |
isolated CHD: ASD/VSD/TGA/DILV/TA/TOF/PS/TA/EA |
unrelated |
523 |
percent predicted forced expiratory volume in 1 s(FEV1) |
isolated CHD: ASD/VSD/TGA/DILV/TA/TOF/PS/TA/EA |
unrelated |
525 |
forced vital capacity(FVC) |
isolated CHD: ASD/VSD/TGA/DILV/TA/TOF/PS/TA/EA |
unrelated |
844 |
Cardiac complications(n=463)--maternal age |
isolated CHD/non-isolated CHD: VSD/VSD, PDA/RV/ASD/PAPVR/AVSD/HCM/AS/AR/MS/TOF/MR/PA/IVS/ccTGA/other |
unrelated |
1059 |
Number of patients taking full oral feeding at discharge (n, %) |
isolated CHD: HLHS/TOF/TGA |
unrelated |
1060 |
Mean length of hospital stay in days (range, SD) |
isolated CHD: HLHS/TOF/TGA |
unrelated |
1246 |
number of surgeries |
isolated CHD/non-isolated CHD: ASD/VSD/PA/AS/CoA/MS/MR/EA/AVC/ALCAPA/D-TGA/Congenitally corrected TGA (s&p double switch)/TA/PA, IVS/SV |
unrelated |
1247 |
anxiety (BAI, Beck anxiety inventory) |
isolated CHD/non-isolated CHD: ASD/VSD/PA/AS/CoA/MS/MR/EA/AVC/ALCAPA/D-TGA/Congenitally corrected TGA (s&p double switch)/TA/PA, IVS/SV |
unrelated |
1248 |
self-efficacy (GSE, general self-efficacy) |
isolated CHD/non-isolated CHD: ASD/VSD/PA/AS/CoA/MS/MR/EA/AVC/ALCAPA/D-TGA/Congenitally corrected TGA (s&p double switch)/TA/PA, IVS/SV |
unrelated |
1600 |
Anxiety symptoms--Yes/No |
isolated CHD/non-isolated CHD: VSD/ASD/VSD/PDA/BAV/TOF/CoA/PV/SAS/AVC/ccTGA/UVA/PA/other |
unrelated |
1779 |
association between pre-operation age and final GFR |
isolated CHD: TOF/PA/VSD/DORV/PS |
unrelated |
1780 |
association between post-operation age and final GFR |
isolated CHD: TOF/PA/VSD/DORV/PS |
unrelated |
1782 |
association between pre-operative HCT and mean uric acid fraction (FEua) excretion |
isolated CHD: TOF/PA/VSD/DORV/PS |
unrelated |
2584 |
association of plasma VWF:Ag with the risk of death adjusted for : age |
isolated CHD/non-isolated CHD: VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
unrelated |
2718 |
association between Qp/Qs and body weight |
NA: NA |
unrelated |
2719 |
association between Qp/Qs and height |
NA: NA |
unrelated |
2721 |
association was observed between pulmonary systolic pressure and weight |
NA: NA |
unrelated |
2722 |
association was observed between pulmonary systolic pressure and height |
NA: NA |
unrelated |
2942 |
correlation between VEGF and SpO2 in CHD |
isolated CHD: TOF/TGA/DORV/VSD/PS/PDA/ASD |
unrelated |
2957 |
correlation between nutritional status(weight-for-age z-score) and mean MEE(measured resting energy expenditure) |
isolated CHD/non-isolated CHD: ASD/AVSD/VSD, ASD/AC/TGA/TOF/VSD/PA, VSD/TOF, PA/TAPVC/PA, VSD/TOF, PDA, RAA/PDA, ASD, AC/DORV, VSD, ASD, PS/PA, VSD |
unrelated |
2958 |
correlation between nutritional status(weight-for-height z-score) and mean MEE(measured resting energy expenditure) |
isolated CHD/non-isolated CHD: ASD/AVSD/VSD, ASD/AC/TGA/TOF/VSD/PA, VSD/TOF, PA/TAPVC/PA, VSD/TOF, PDA, RAA/PDA, ASD, AC/DORV, VSD, ASD, PS/PA, VSD |
unrelated |
3018 |
correlation between LV SDI and LV ejection fraction in patients |
isolated CHD: TOF/VSD |
unrelated |
3019 |
correlation between LV SDI and LV ejection fraction in patients |
isolated CHD: TOF/VSD |
unrelated |
3020 |
correlation between LV SDI and LV ejection fraction in patients |
isolated CHD: TOF/VSD |
unrelated |
3042 |
correlation between RR interval and SDI |
isolated CHD: TOF/VSD |
unrelated |
3043 |
correlation between RR interval and SDI |
isolated CHD: TOF/VSD |
unrelated |
3118 |
Father's education level |
isolated CHD: VSD/PDA/TOF/ASD/PS/other |
unrelated |
3119 |
Mother's education level |
isolated CHD: VSD/PDA/TOF/ASD/PS/other |
unrelated |
3120 |
Fetal order |
isolated CHD: VSD/PDA/TOF/ASD/PS/other |
unrelated |
3121 |
Neonatal asphyxia or hypoxia (yes/no) |
isolated CHD: VSD/PDA/TOF/ASD/PS/other |
unrelated |
3122 |
Mother's age at this pregnancy |
isolated CHD: VSD/PDA/TOF/ASD/PS/other |
unrelated |
3123 |
Father's age at this pregnancy |
isolated CHD: VSD/PDA/TOF/ASD/PS/other |
unrelated |
3124 |
consanguineous marriage (yes/no) |
isolated CHD: VSD/PDA/TOF/ASD/PS/other |
unrelated |
3125 |
consanguineous marriage (yes/no) |
isolated CHD: VSD/PDA/TOF/ASD/PS/other |
unrelated |
3126 |
Father's occupational exposure (yes/no) |
isolated CHD: VSD/PDA/TOF/ASD/PS/other |
unrelated |
3127 |
gynecologic examinations (yes/no) |
isolated CHD: VSD/PDA/TOF/ASD/PS/other |
unrelated |
3128 |
gestational weeks until aware of pregnancy |
isolated CHD: VSD/PDA/TOF/ASD/PS/other |
unrelated |
3129 |
maternal upper respiratory infection (yes/no) |
isolated CHD: VSD/PDA/TOF/ASD/PS/other |
unrelated |
3130 |
maternal fever (yes/no) |
isolated CHD: VSD/PDA/TOF/ASD/PS/other |
unrelated |
3131 |
number of previous pregnancies |
isolated CHD: VSD/PDA/TOF/ASD/PS/other |
unrelated |
3132 |
history of spontaneous abortion (yes/no) |
isolated CHD: VSD/PDA/TOF/ASD/PS/other |
unrelated |
3133 |
number of spontaneous abortions |
isolated CHD: VSD/PDA/TOF/ASD/PS/other |
unrelated |
3134 |
maternal infection (yes/no) |
isolated CHD: VSD/PDA/TOF/ASD/PS/other |
unrelated |
3135 |
maternal medication (yes/no) |
isolated CHD: VSD/PDA/TOF/ASD/PS/other |
unrelated |
3136 |
maternal B-mode ultrasound examination (yes/no) |
isolated CHD: VSD/PDA/TOF/ASD/PS/other |
unrelated |
3137 |
new house repair or relocation (yes/no) |
isolated CHD: VSD/PDA/TOF/ASD/PS/other |
unrelated |
3138 |
maternal mental stress |
isolated CHD: VSD/PDA/TOF/ASD/PS/other |
unrelated |
3139 |
Father drank before and during the first month of pregnancy (quit or never drank/yes) |
isolated CHD: VSD/PDA/TOF/ASD/PS/other |
unrelated |
3191 |
risk of IE with foreign material implantation undergoing cardiac surgery |
isolated CHD/non-isolated CHD: BAV/MVP/VSD/AS/BAV, VSD, ASD/AV/AS, AI/TOF/PA, VSD, RPA/AVSD, PS |
unrelated |
3243 |
height (per cm) |
isolated CHD/non-isolated CHD: HLHS/VSD, PS/UVH, PS/PATR, TOF/UVH/CAT/CAT, IAA/VSD, ASDII/AVSD/VSD, ASD/TGA, AVSD, IAA/AVSD/IAA, VSD, ASD/HLHS/AVSD/TGA, PATR, VSD/TGA/VSD/AVSD/TAPVD/DORV/other |
unrelated |
3435 |
correlation between lower peak VO2 and higher VE/VCO2 slope |
isolated CHD/non-isolated CHD: ASD/AVSD/ccTGA/CoA/other/EA/ES/TOF/CHD with PAH/VSD |
unrelated |
3761 |
vomiting |
isolated CHD: VSD/ASD/TOF/CoA/persistent ducts/PVS/AVS/complete TGA/STPVCA |
unrelated |
3862 |
quantitative indexes: TPV correlation with systolic and mean PA pressure |
NA: NA |
unrelated |
3864 |
quantitative indexes: TPV/RVET correlation with systolic and mean PA pressure |
NA: NA |
unrelated |
4005 |
Parent domain at 6 months of age |
NA: NA |
unrelated |
4006 |
Parent domain at 12 months of age |
NA: NA |
unrelated |
4007 |
total stress at 12 months of age |
NA: NA |
unrelated |
4042 |
eGFR |
isolated CHD: PDA/VSD/DORV/ASD/p-AVSD/PAPVR |
unrelated |
4043 |
Oxygen delivery |
isolated CHD: PDA/VSD/DORV/ASD/p-AVSD/PAPVR |
unrelated |
4044 |
CaO2 |
isolated CHD: PDA/VSD/DORV/ASD/p-AVSD/PAPVR |
unrelated |
4045 |
Body surface area |
isolated CHD: PDA/VSD/DORV/ASD/p-AVSD/PAPVR |
unrelated |
4046 |
Age |
isolated CHD: PDA/VSD/DORV/ASD/p-AVSD/PAPVR |
unrelated |
4055 |
correlation between PASP(pulmonary artery systolic pressure ) and miR-204 expression in mild group |
isolated CHD/non-isolated CHD: VSD/ASD/VSD, ASD/PDA/VSD, PDA/ASD, PDA |
unrelated |
4056 |
correlation between PASP(pulmonary artery systolic pressure ) and miR-204 expression in severe group |
isolated CHD/non-isolated CHD: VSD/ASD/VSD, ASD/PDA/VSD, PDA/ASD, PDA |
unrelated |
4057 |
correlation between PASP(pulmonary artery systolic pressure ) and miR-204 expression in all CHD group |
isolated CHD/non-isolated CHD: VSD/ASD/VSD, ASD/PDA/VSD, PDA/ASD, PDA |
unrelated |
4171 |
Relative mortality risk after pulmonary valve replacement(age brackets of 35–40) |
isolated CHD: TOF |
unrelated |
4173 |
Relative mortality risk after pulmonary valve replacement(age brackets of >50) |
isolated CHD: TOF |
unrelated |